Human milk in disease: lipid composition.
Differences in the lipid composition of human milk have been described in maternal diseases known to affect fat metabolism. Diseases such as diabetes, cystic fibrosis, hypobetalipoproteinemia and Type I hyperlipoproteinemia affect the quantity and quality of human milk fat. Increased fatty acid chain elongation and changes in desaturation (especially delta 6 desaturase), as well as changes in lipid class composition, have been shown in diabetes and cystic fibrosis, whereas compensatory increases in medium-chain fatty acids have been described in hypobetalipoproteinemia and Type I hyperlipoproteinemia. It is important to realize that these observations were made either on single women or on very small groups of women. In infant diseases, such as breast milk jaundice and ectopic eczema, changes in polyunsaturated fatty acids in maternal milk have been described.
Hamosh
M
M
Department of Pediatrics, Georgetown University Medical Center, Washington, D.C. 20007.
Bitman
J
J
D003550:Cystic Fibrosis / Q000378:metabolism*; D003876:Dermatitis, Atopic / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000378:metabolism; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000378:metabolism*; D050356:Lipid Metabolism; D008659:Metabolic Diseases / Q000378:metabolism*; D008895:Milk, Human / Q000378:metabolism*